简介

Professor Michael Mahan's research concerns the molecular mechanisms of bacterial pathogenesis; and innate and adaptive immune responses to infection. He received his B.S. degree in Biochemistry and M.S. degree in Genetics from the University of California, Davis; and a Ph.D. in Genetics from the University of Utah. He was a NIH post-doctoral fellow at Harvard Medical School where he began his work on the molecular mechanisms of underlying Salmonella pathogenesis. Dr. Mahan joined the UCSB faculty in 1993. Dr. Mahan shared the American Association for the Advancement of Science (AAAS) Newcomb-Cleveland Prize for the outstanding paper published in Science. He is a recipient of an American Cancer Society Junior Faculty Research Award; Beckman Young Investigator Award; Harold J. Plous Award; USDA National Impact Paper; and Faculty Distinguished Teaching Award. Dr. Mahan served on the Editorial Board for the Journal of Molecular Medicine was Co-founder and Director of Remedyne Corporation, a biotech company in Santa Barbara, California.